Sightsavers Logo
Research centre
  • Home
  • About us
  • Research approach
  • Research studies and publications
  • Evidence gap maps
Join in:
  • Join in: Facebook
  • Join in: Twitter
  • Join in: Instagram
  • Join in: LinkedIn
  • Join in: YouTube
  • Global
  • Close search bar
    Donate
    • Home
    • About us
    • Research approach
    • Research studies and publications
    • Evidence gap maps
    Publication

    Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control

    Journal: Parasites & Vectors

    Summary

    This paper reports on the impact of 15 to 17 years of ivermectin treatment in two onchocerciasis foci in Kaduna State, Nigeria. In 2008, an epidemiological evaluation using the skin snip parasitological diagnostic method was undertaken in 26 villages and 3,703 people above the age of one year examined. The result was compared with the baseline survey undertaken in 1987.

    Before treatment, the community prevalence of Onchocerca volvulus microfilaria in the skin ranged from 23.1% to 84.9%. After 15 to 17 years of treatment, the prevalence had fallen to 0% in all communities and all examined individuals were skin snip negative. The results of the surveys confirm an earlier finding from Senegal and Mali that ivermectin treatment alone can eliminate onchocerciasis infection and probably disease transmission in endemic foci in Africa.

    Read the journal article

    Related tags

    Nigeria
    Onchocerciasis
    Publication details
    Date published
    7 February 2012
    Journal
    Parasites & Vectors
    Countries
    Nigeria
    Themes/conditions
    Onchocerciasis
    Publication details
    Date published
    7 February 2012
    Journal
    Parasites & Vectors
    Countries
    Nigeria
    Themes/conditions
    Onchocerciasis

    Related publications

    Publication

    Persistent transmission of onchocerciasis in Kwanware-Ottou focus in Wenchi health district, Ghana

    Publication

    Progress towards elimination of onchocerciasis transmission in Mali: a “pre-stop MDA” survey in 18 transmission zones

    Publication

    Ivermectin and doxycycline treatments against onchocerciasis: adaptations and impact among semi-nomadic population in Massangam health district, Cameroon

    Sightsavers Logo
    Research centre
    • Join in:
    • Join in: Facebook
    • Join in: X
    • Join in: Instagram
    • Join in: LinkedIn
    • Join in: YouTube

    Protecting sight, fighting disease and promoting equality for all

  • Accessibility
  • Sightsavers homepage
  • Our policies
  • Media centre
  • Contact us
  • Jobs
  • Cookies and privacy Terms and conditions Modern slavery statement Safeguarding

    © 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.

    Our website uses cookies

    To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.

    Manage preferences

    You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.

    Essential cookiesAlways on

    These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.

    Analytics cookies

    To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.

    Advertising cookies

    To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.